X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-17
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs643316-   
Low Rs503228-   
Sales per share (Unadj.) Rs254.494.0-  
Earnings per share (Unadj.) Rs16.1-23.7-  
Cash flow per share (Unadj.) Rs29.8-19.6-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs194.673.8-  
Shares outstanding (eoy) m126.20168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.32.9 77.8%   
Avg P/E ratio x35.7-11.5 -310.5%  
P/CF ratio (eoy) x19.2-13.9 -138.9%  
Price / Book Value ratio x2.93.7 79.9%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m72,30045,919 157.5%   
No. of employees `00013.34.3 309.9%   
Total wages/salary Rs m6,9602,882 241.5%   
Avg. sales/employee Rs Th2,413.53,696.8 65.3%   
Avg. wages/employee Rs Th523.2671.3 77.9%   
Avg. net profit/employee Rs Th152.4-931.5 -16.4%   
INCOME DATA
Net Sales Rs m32,10615,870 202.3%  
Other income Rs m226111 203.1%   
Total revenues Rs m32,33215,982 202.3%   
Gross profit Rs m4,448-2,750 -161.7%  
Depreciation Rs m1,730685 252.5%   
Interest Rs m241430 56.0%   
Profit before tax Rs m2,703-3,754 -72.0%   
Minority Interest Rs m0-10 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m675235 287.8%   
Profit after tax Rs m2,028-3,999 -50.7%  
Gross profit margin %13.9-17.3 -79.9%  
Effective tax rate %25.0-6.2 -399.7%   
Net profit margin %6.3-25.2 -25.1%  
BALANCE SHEET DATA
Current assets Rs m17,34011,624 149.2%   
Current liabilities Rs m9,5596,540 146.2%   
Net working cap to sales %24.232.0 75.7%  
Current ratio x1.81.8 102.1%  
Inventory Days Days100111 90.4%  
Debtors Days Days57124 45.9%  
Net fixed assets Rs m20,7796,775 306.7%   
Share capital Rs m25274 342.5%   
"Free" reserves Rs m24,4990-   
Net worth Rs m24,55312,457 197.1%   
Long term debt Rs m3,5174,377 80.4%   
Total assets Rs m39,59523,531 168.3%  
Interest coverage x12.2-7.7 -158.1%   
Debt to equity ratio x0.10.4 40.8%  
Sales to assets ratio x0.80.7 120.2%   
Return on assets %5.7-15.2 -37.8%  
Return on equity %8.3-32.1 -25.7%  
Return on capital %10.5-19.8 -52.9%  
Exports to sales %48.60-   
Imports to sales %14.20-   
Net fx Rs m9,7900-   
CASH FLOW
From Operations Rs m2,7641,355 204.1%  
From Investments Rs m-1,432-416 344.2%  
From Financial Activity Rs m-1,5913,973 -40.1%  
Net Cashflow Rs m-2594,912 -5.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.36 Rs / ZAR

Compare IPCA LABS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: DR. DATSONS LABS  SUVEN LIFE  PANACEA BIOTECH  WYETH LTD  CIPLA  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Aug 17, 2017 03:16 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - PANACEA BIOTECH COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS